Abstinence Carlat Reports | Carlat Publishing

Expert Q&A

Personal Privacy Versus Public Safety: Addiction Among Health Professionals

From The Carlat Addiction Treatment Report, Substance Use in Health Professionals

CATR: Tell us how your interest in addiction came about. Dr. Earley: When I started working in the world of addiction treatment 35 years ago, there wasn’t much specific training. I was trained as a neurologist and always had an interest in patients with substance use disorders. Ultimately, I decided to shift my specialty and wound up cobbling togethe

Clinical Update

Learning From the Successes of Physician Health Programs

From The Carlat Addiction Treatment Report, Substance Use in Health Professionals

The rate of substance use disorders among physicians is around the same if not slightly higher than in the general population. Impaired physicians, however, are a public health threat, and in most states there is mandated reporting of impaired physicians (Mossman D, Current Psychiatry 2011; 10(9):67–71). So what is to be done for an addicted or im

Research Update

E-Cigarettes vs Nicotine Replacement for Smoking Cessation

From The Carlat Addiction Treatment Report, Emerging Risks for Old Medications

Topics: Abstinence | E-Cigarettes | Research Update | smoking cessations | tobacco research

Review of: Hajek P et al, N Engl J Med 2019;380(7):629–637 E-cigarettes are increasingly popular, often touted as exposing users to fewer toxins than combustible cigarettes. Might they be useful for smoking cessation and abstinence? To answer this question, Hajek et al performed a multicenter randomized controlled trial comparing e-cigarettes to ni

Clinical Update

Disulfiram: An Underused Strategy for Alcohol Use Disorders

From The Carlat Psychiatry Report, Depression

Alcohol ranks third among preventable causes of death in the US, but it is by far the most undertreated. Fewer than 8% of people with alcohol use disorders (AUDs) receive treatment for their disease, and only a minority of them receive FDA-approved medications. Those medications are acamprosate (Campral), naltrexone (Vivitrol, ReVia), and disulfiram (An